Skip to main content
TipRanks
Go Ultimate75% OFF

Devonian Health Group (GSD) Stock Statistics & Valuation Metrics

6 Followers

Total Valuation

Devonian Health Group has a market cap or net worth of CAD 17.52M. The enterprise value is CAD 32.37M.

Market Cap
CAD 17.52M
Enterprise Value
CAD 32.37M

Share Statistics

Devonian Health Group has 2,780,866 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
2,780,866
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Devonian Health Group’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)
―
Return on Assets (ROA)
―
Return on Invested Capital (ROIC)
―
Return on Capital Employed (ROCE)
―
Revenue Per Employee
―
Profits Per Employee
-397.79K
Employee Count
11
Asset Turnover
―
Inventory Turnover
―

Income Statement

In the last 12 months, Devonian Health Group had revenue of ― and earned -4.38M in profits. Earnings per share was ―.

Revenue
―
Gross Profit
0
Operating Income
-1.94M
Pretax Income
―
Net Income
-4.38M
EBITDA
-3.28M
Earnings Per Share (EPS)
―

Stock Price Statistics

Beta
0.42
52-Week Price Change
-47.50%
50-Day Moving Average
7.78
200-Day Moving Average
9.84
Relative Strength Index (RSI)
37.75
Average Volume (3m)
3,612

Important Dates

Devonian Health Group upcoming earnings date is Dec 02, 2026, TBA (Not Confirmed).

Last Earnings Date
Jun 29, 2026
Next Earnings Date
Dec 02, 2026
Ex-Dividend Date
―

Balance Sheet

Devonian Health Group has ― in cash and marketable securities with CAD 4.76M in debt, giving a net cash position of ― billion.

Cash & Marketable Securities
―
Total Debt
CAD 4.76M
Net Cash
―
Net Cash Per Share
―
Tangible Book Value Per Share
―

Analyst Forecast

The average price target for Devonian Health Group is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
-90.48%
EPS Growth Forecast
-20.65%